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Introduction: Currently, the design of extracellular matrix (ECM) with nanoscale properties in 
bone tissue engineering is challenging. For bone tissue engineering, the ECM must have certain 
properties such as being nontoxic, highly porous, and should not cause foreign body reactions.
Materials and methods: In this study, the hybrid scaffold based on polyvinyl alcohol (PVA) 
blended with metallocene polyethylene (mPE) and plectranthus amboinicus (PA) was fabricated for 
bone tissue engineering via electrospinning. The fabricated hybrid nanocomposites were character-
ized by scanning electron microscopy (SEM), Fourier transform and infrared spectroscopy (FTIR), 
thermogravimetric analysis (TGA), contact angle measurement, and atomic force microscopy (AFM). 
Furthermore, activated partial thromboplastin time (APTT), prothrombin time (PT), and hemolytic 
assays were used to investigate the blood compatibility of the prepared hybrid nanocomposites.
Results: The prepared hybrid nanocomposites showed reduced fiber diameter (238±45 nm) 
and also increased porosity (87%) with decreased pore diameter (340±86 nm) compared with 
pure PVA. The interactions between PVA, mPE, and PA were identified by the formation of the 
additional peaks as revealed in FTIR. Furthermore, the prepared hybrid nanocomposites showed a 
decreased contact angle of 51°±1.32° indicating a hydrophilic nature and exhibited lower thermal 
stability compared to pristine PVA. Moreover, the mechanical results revealed that the electrospun 
scaffold showed an improved tensile strength of 3.55±0.29 MPa compared with the pristine PVA 
(1.8±0.52 MPa). The prepared hybrid nanocomposites showed delayed blood clotting as noted in 
APTT and PT assays indicating better blood compatibility. Moreover, the hemolysis assay revealed 
that the hybrid nanocomposites exhibited a low hemolytic index of 0.6% compared with pure PVA, 
which was 1.6% suggesting the safety of the developed nanocomposite to red blood cells (RBCs).
Conclusion: The prepared nanocomposites exhibited better physico-chemical properties, 
sufficient porosity, mechanical strength, and blood compatibility, which favors it as a valuable 
candidate in bone tissue engineering for repairing the bone defects.
Keywords: scaffold, electrospinning, bone tissue engineering, physico-chemical characteriza-
tion, blood compatibility
Introduction
Finding clinical applications for the repair of massive bone defects produced by dis-
ease or trauma is a challenge. The diseases or traumas included in this list are tumor 
ablation, bone cysts, osteolysis, and neurosurgical defects.1 Recently, in biomedical 
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applications, bone tissue engineering is promising as a 
new approach for bone repair. The tissue-engineered bone 
scaffold helps in eliminating problems of donor scarcity, 
supply limitation, pathogen transfer, and immune rejection 
compared to traditional autograft and allograft procedures.2 
Moreover, tissue-engineered bone possesses an extracel-
lular matrix (ECM), which helps in promoting osteoblast 
proliferation for the differentiation, growth, and mineralized 
tissue formation.3,4 The ideal scaffold in bone tissue engineer-
ing must be biocompatible, biodegradable, nontoxic, and 
highly porous and should not cause foreign body reactions. 
Furthermore, it should have significant mechanical and 
physical properties in order to meet the need of bone tissue 
engineering.5,6 Currently, a variety of materials are utilized 
in repairing the damaged or traumatized bone tissue. The 
materials include metals, ceramics, and polymers (natural 
and synthetic).7 Owing to many disadvantages in metals 
and ceramics, such as lack of degradability in a biological 
environment and limited process ability, their utilization in 
bone tissue-engineering applications is restricted.8 In con-
trast, polymers are attractive due to design flexibility and 
may be easily tailored according to the specific needs.9 The 
commonly used polymers in bone tissue engineering are 
poly(lactic acid), poly(glycolic acid), poly(lactic-co-glycolic 
acid) (PLGA), poly(caprolactone), and natural polymers such 
as collagen, gelatin, silk, and chitosan.10
The design of scaffolds as ECM in guiding the tissue 
regeneration process is still challenging in bone tissue 
engineering. For tissue-engineering applications, the fabri-
cated scaffolds should imitate the biological functions and 
also resemble the structure of the ECM.4,11,12 Moreover, the 
developed scaffolds should provide sufficient mechanical 
support to direct the inductive molecules or cells to the 
repair site for the generation of new tissue growth. There 
are many techniques such as particle leaching, phase separa-
tion, and self-assembly to develop three-dimensional porous 
architectures.3,4 However, the scaffolds developed using 
these techniques do not effectively imitate the structure of 
the natural ECM, which limits the bone tissue formation.4 
ECM is a natural composite in which the fibrous collagens 
are embedded in a three-dimensional porous network. The 
hierarchical 3D porous structure was made of collagen 
fibers with tissue architecture that ranges from nanometer to 
macroscopic dimensions.13 The scaffold generated by an elec-
trospinning technique has nanoscale fibers that resemble the 
topographic features of the ECM. Nowadays, the electrospun 
fibrous scaffold has been widely used for tissue engineering. 
Moreover, many studies have focused on processing the 
various natural and synthetic polymers in fabricating porous 
scaffold for tissue-engineering applications.11,14–16
Electrospinning is a versatile and cost-effective technique 
that produces fibers in nanoscale diameters with the aid of a 
high electric field. In the electrospinning setup, the polymer 
solution in a syringe needle is subjected to an electric field 
and the polymer jet is converted into nanofibers when the 
electric field overcomes the threshold voltage. The result-
ing nanofibers are deposited in the form of a nonwoven 
fabric on the collector drum. Electrospinning is a versatile 
technique for fabricating the scaffold for tissue-engineered 
applications because control of fiber diameters and poros-
ity may be performed by adjusting solution properties and 
operating parameters.17–19 In this study, the polymer used 
in fabricating the scaffold was polyvinyl alcohol (PVA). 
The various applications of PVA composites in biomedi-
cal applications include manufacturing of contact lenses, 
artificial heart surgery, drug delivery systems, and wound 
dressings.20 Furthermore, PVA is used as a biomaterial in 
medical devices because of its favorable properties such as 
biocompatibility, nontoxicity, noncarcinogenicity, swelling 
properties, and bioadhesive characteristics.21
Another material used in this study was metallocene 
polyethylene (mPE). The metallocene-based polyolefins 
possess enhanced toughness, seal ability, clarity, and 
elasticity.22 mPE provides excellent permeability to oxygen 
and also acts as a barrier toward ammonia and water. 
Currently, mPE is used in many medical applications such 
as disposable bags, storage bottles, blood bags, and syringe 
tubes.23 Generally, the use of PVA in certain applications is 
limited by low strength20 and it is hypothesized that adding 
mPE will provide suitable strength to the electrospun mem-
brane. Furthermore, leaves of plectranthus amboinicus (PA) 
were blended with the composite to improve its properties. 
The leaves of PA have been used as flavoring agents in meat 
and poultry, as ornamentals, and also as essential oils. PA 
leaves were also utilized for other ranges of problems such as 
infections, rheumatism, and flatulence.24,25 The constituents of 
PA were reported to have various bioactivities such as anti-
oxidant, antibacterial, antimicrobial, antifungal, and wound 
healing activities. Moreover, the constituents of PA were 
found to possess anti-inflammatory activity inhibiting the 
activator protein-1 (AP-1) and tumor necrosis factor (TNF-α), 
which are vital for the pathogenesis of inflammatory bone 
resorption.26 In this study, a novel bionanocomposite based 
on PVA blended with mPE and PA will be fabricated using 
a single-step electrospinning process. The aim of this study 
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Development and blood compatibility assessment of electrospun PVa/mPe/Pa
characterization and mechanical properties of the developed 
nanocomposite. Furthermore, blood compatibility assays 
were performed to assess the safety of the fabricated nano-
composite along with the pure PVA nanofibers.
Materials and methods
Materials
The following materials were used in this study: PVA was 
from Sigma-Aldrich Co. (St Louis, MO, USA); mPE sheets 
were gifts from Indian Institute of Technology (Kharagpur, 
India); fresh leaves of PA were obtained locally; phosphate-
buffered saline (PBS) and physiological saline (0.9%, w/v) 
were from Sigma-Aldrich Co.; and the coagulation assay 
reagents were from Diagnostic Enterprises (Solan, India).
Preparation of nanocomposite
Distilled water was used as a solvent for PVA, and 10 wt% 
of PVA was used for the preparation of the nanocomposite. 
To prepare 10 wt% of PVA, 0.70 g of PVA polymer was 
mixed in 7 mL of distilled water and stirred for 12 h at room 
temperature to obtain a clear homogeneous solution. Both 
mPE and PA were incorporated into the PVA matrix at a 
concentration of 1 wt%. To prepare 1 wt% of mPE, 0.030 g 
of mPE was mixed in 3 mL of xylene and stirred for 24 h 
until the homogeneous solution was obtained. Similarly, the 
homogeneous solution of PA was obtained by adding 30 µL 
of PA in 3 mL of distilled water and stirred for 3 h at room 
temperature. Finally, the PVA/mPE/PA nanocomposite was 
obtained by adding the prepared homogeneous solution of 
mPE and PA solutions in PVA at the ratio of 8:1:1 (v/v) and 
stirred for 2 h for the uniform dispersion.
Fabrication of PVa and nanocomposite 
dressing
The pure PVA nanofiber and PVA/mPE/PA nanocomposites 
were obtained by an electrospinning technique. Electro-
spinning of both PVA and PVA/mPE/PA nanofibers was 
performed at an applied voltage of 10 kV with a flow rate 
of 0.5 mL/h. The obtained nanofibers were deposited on 
the collector, which was placed at 17 cm from the tip of the 
needle. The fabricated PVA and PVA/mPE/PA scaffolds 
were dried at room temperature under vacuum.
Physico-chemical characterizations
scanning electron microscopy (seM) micrographs
The electrospun PVA and PVA/mPE/PA nanocomposites 
were investigated using the Tabletop TM-300 (Hitachi 
Ltd., Tokyo, Japan) to analyze the morphological features. 
Before obtaining microphotographs, the fabricated membranes 
were coated with gold and the average fiber diameter was cal-
culated using the ImageJ software (Bethesda, MD, USA).
Attenuated total reflectance Fourier transform 
infrared spectroscopy (aTr-FTIr) analysis
The spectra of electrospun PVA and PVA/mPE/PA were 
obtained using the Nicolet iS5 ATR-FTIR unit (Thermo 
Fischer Scientific, Waltham, MA, USA). Initially, the 
samples of electrospun PVA and PVA/mPE/PA were placed 
on the sensor and scanned at a resolution of 4/cm in the fre-
quency range of 600–4,000 cm-1 to examine the presence of 
characteristic peaks.
Porosity and pore size measurement
The density bottle method was used to measure the porosity 
percentage of the pure PVA and the prepared PVA/mPE/PA. 
Then, the apparent density (ρ
i








Thickness (t) Area of  the sample 1 w× × ( )  
(1)
After calculating the apparent density (ρ
i
) and the bulk/
standard density ρ
0
 of PVA, the values were placed in the 
following equation to calculate the porosity percentage (ε):
 
Porosity percentage 1 100%
0









Finally, the average pore size diameter in both PVA and 
PVA/mPE/PA was calculated using ImageJ and the obtained 
values were explored into the Excel sheet to draw the pore 
size distribution.
contact angle measurements
The wettability of electrospun PVA and PVA/mPE/PA was 
calculated using the VCA Optima (AST Products, Inc., 
Billerica, MA, USA) contact angle measurement unit. The 
measurement was performed by placing a water drop on the 
sample, and the image of the water droplet on the membranes 
was captured using high-resolution camera. From the cap-
tured image, the mean contact angles were calculated using 
the computer-integrated software.
Thermogravimetric analysis (Tga)
The thermal properties of electrospun PVA and PVA/mPE/





































































Powered by TCPDF (www.tcpdf.org)
                               1 / 1





Inc., Waltham, MA, USA). The thermal properties were 
determined by heating a sample weighing 3 mg from 50 to 
1,000°C at 10°C/min.
Mechanical testing
The mechanical testing was measured according to ASTM 
D638-98 standard using a uniaxial load test machine (AI-3000; 
Gotech Testing Machines, Taichung, Taiwan). To begin, a small 
piece of electrospun PVA and PVA/mPE/PA was mounted 
on its cut ends and the testing was carried out at a cross-head 
speed of 5 mm/min until the onset failure occurs. Then, the 
tensile strength and Young’s modulus (modulus of elasticity) 
were calculated from the slope of the stress–strain curve.
Functionalization of PVa and PVa/mPe/Pa 
nanocomposites
Functionalization was performed through a heating method. 
Samples with a size of 2×2 cm2 were cut and placed on the 
heating unit. Heating was performed at 70°C for 7 days in 
room temperature continuously.27 After heating, the samples 
were weighed (W
d
) and then immersed into warm distilled 
water (37.0°C) for 1, 7, and 14 days.28 After 1, 7, and 
14 days, the samples were taken out and the weight of the 
immersed samples (Wi) was measured after drying. Finally, 
the solubility in water for both samples was calculated.
Blood compatibility assessments
ethical approval and blood sample procurement
The coagulation assay procedures were approved by the 
Chairman, Ethical and Medical Researcher Committee, 
Universiti Tekonologi Malaysia, with the ref no UTM.J.45.01/ 
25.10/3Jld.2(3). Before the procedures, a written consent 
form was given to the healthy volunteers. They were 
informed about the risks and benefits and they signed the 
informed consent before blood withdrawal. The blood col-
lection and the preparation of platelet-poor plasma (PPP) 
were carried out as reported in previous work.29
activated partial thromboplastin time (aPTT)
The APTT assay was used to measure the activation of 
intrinsic pathway to detect the blood compatibility of pure 
PVA nanofiber and PVA/mPE/PA nanocomposite. To begin, 
the samples of PVA nanofiber and PVA/mPE/PA nanocom-
posite were added to 100 µL of PPP and incubated at 37°C. 
Then, the mixture was added with 100 µL of rabbit brain ceph-
alin followed by adding 50 µL of CaCl
2
. Finally, the mixture 
was stirred using a needle and time taken for the appearance 
of the initial clot was measured using a chronometer.29
Prothrombin time (PT)
PT was calculated for pure PVA nanofiber and PVA/mPE/PA 
nanocomposite to investigate the activation of the extrinsic 
pathway. For the PT assay, cut samples of fabricated 
pure PVA nanofiber and PVA/mPE/PA nanocomposite 
(0.5×0.5 cm2) were added with 100 µL of PPP and incubated 
at 37°C. Then, the mixture was activated by adding 0.9% of 
NaCl-thromboplastin (Factor III, 100 mL)-containing Ca2+ 
ions and the initiation for clot formation was identified using 
a chronometer.29
hemolysis assay
To begin this assay, the fabricated pure PVA nanofiber and 
PVA/mPE/PA were cut into small pieces with the dimension 
of 1×1 cm and equilibrated in 4 mL of saline for 30 min at 
37°C. After that, the samples were exposed to 0.2 mL of 
diluted blood and incubated for 60 min at 37°C. The posi-
tive and negative controls were constituted by mixing human 
blood into distilled water in the ratio 4:5 (100% hemolysis) 
and the physiological saline solution, respectively. Then, the 
mixture was retrieved and centrifuged at 1,000 rpm for 5 min. 
After that, the absorbance of the supernatant was measured 
at 545 nm, which represents the damage of red blood cell 
(RBC). The percentage of hemolysis or hemolytic index was 
calculated using the protocol as described earlier.29
statistical analysis
In this study, all the experiments were performed thrice inde-
pendently. Using unpaired t-test, the statistical significance 




The SEM images denote the morphology of the electrospun 
PVA and PVA/mPE/PA nanocomposites. The SEM analysis 
clearly indicates that the electrospun PVA and PVA/mPE/
PA nanocomposites possessed beadless fibers as shown in 
Figure 1A and B. The fiber diameters of PVA and PVA/
mPE/PA nanocomposites were found to be 326±56 and 
238±45 nm, respectively. The obtained results clearly showed 
that the PVA/mPE/PA nanocomposites showed reduced fiber 
diameter compared to pure PVA. The corresponding fiber 
distribution curve for the electrospun PVA and PVA/mPE/
PA nanocomposites are shown in Figure 2A and B. Linh 
and Lee utilized PVA scaffold blended with gelatin for bone 
tissue engineering application. It was observed that the fiber 
diameter of electrospun PVA nanofibers was 250±20 nm, 
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Development and blood compatibility assessment of electrospun PVa/mPe/Pa
range of 150±10 nm. Furthermore, the PVA/gelatin scaffold 
with smaller fiber diameter showed enhanced osteoblast 
proliferation compared to pure PVA.30 In our study, the fiber 
diameter of electrospun PVA/mPE/PA nanocomposites was 
found to be of similar range, which seems to be conducive 
for enhanced bone tissue growth.
aTr-FTIr analysis
The characteristic peaks present in the PVA, mPE, PA, and 
PVA/mPE/PA are indicated in Figure 3. In the absorption 
band of PVA, a broad band visible at 3,325 cm-1 signals the 
OH group. A sharp peak seen at 2,918 cm-1 denotes the CH 
stretching, and the peaks at 1,375 and 1,435 cm-1 indicate 
Figure 1 seM images of (A) PVa membrane and (B) PVa/mPe/Pa nanocomposites.
Abbreviations: mPe, metallocene polyethylene; Pa, plectranthus amboinicus; PVa, polyvinyl alcohol; seM, scanning electron microscopy.
Figure 2 Fiber distribution curves of (A) PVa membrane and (B) PVa/mPe/Pa nanocomposites.
Note: *Mean differences were significant compared with pure PVA (P,0.05).
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CH vibrations. The presence of carboxylic (C=O) stretch-
ing was observed at 1,732, and bands at 1,246, 1,092, 843, 
and 607 cm-1 indicate the C-O stretching corresponding to 
alcohol groups.31,32 Similarly, in the mPE spectrum, a sharp 
twin peak at 2,917 and 2,849 cm-1 indicating the CH stretch-
ing and the vibrations of CH stretching was identified by the 
characteristic bands at 1,371 and 1,468 cm-1, respectively. 
Furthermore, a band seen at 1,737 cm-1 indicates the C-O 
stretching and their vibrations of C-O corresponding to alco-
hol were seen at 1,237, 1,019, and 719 cm-1, respectively.33 
Similarly, in the IR spectrum of PA, a wide band observed 
at 3,345 cm-1 indicates the OH stretching and a sharp peak 
at 1,634 cm-1 indicates the C=O stretching. From the IR 
spectrum of PVA/mPE/PA nanocomposites, it was observed 
that the intensity of the absorption bands was increased due to 
the formation of the OH bond.34 Furthermore, the formation 
of additional bands at the peak of 1,645 and 1,539 cm-1 was 
attributed to the vibrations of OH group, which clearly indi-
cate the interaction between the PVA, mPE, and PA.35 The 
interaction between PVA, mPE, and PA was also identified 
by a shifting of the OH group to a lower wave number from 
3,325 cm-1 in pure PVA to 3,292 cm-1 in PVA/m PE/PA, con-
firming the addition of mPE and PA in the PVA matrix.34
Porosity measurements
The results of percentage porosity are shown in Figure 4. 
The pure PVA membrane exhibited a mean porosity of 76%, 
whereas in the fabricated PVA/mPE/PA, the porosity was 
found to be 87%. The results clearly show that the PVA/
mPE/PA membrane has high porosity ~8.8% enhance-
ment compared to pure PVA. Furthermore, the fabricated 
PVA/mPE/PA membrane showed a decrease in pore size 
diameter compared to control as indicated in Figure 5. The 
developed nanocomposite mesh exhibited a pore diameter 
of 340±86 nm, while for the pure PVA, the pore size diam-
eter was found to be 460±53 nm. Sicchieri et al prepared 
PLGA–calcium phosphate (CaP) scaffolds for bone tissue 
engineering. It was reported that the scaffold with low pore 
Figure 3 Infrared spectrum of PVa membrane, mPe, Pa, and PVa/mPe/Pa nanocomposites.
Abbreviations: mPe, metallocene polyethylene; Pa, plectranthus amboinicus; PVa, polyvinyl alcohol.
Figure 4 Porosity percentage of PVa membrane and PVa/mPe/Pa nanocom-
posites.
Note: *Mean differences were significant compared with pure PVA (P,0.05).
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Development and blood compatibility assessment of electrospun PVa/mPe/Pa
size diameter showed enhanced osteoblast cell response and 
favored enhanced bone formation.36 Hence, the fabricated 
novel nanocomposites with decreased pore size diameter 
might be favorable for the new bone tissue formation.
Wettability
The wettability of electrospun PVA and PVA/mPE/PA is 
shown in Table 1. The contact angle measurements revealed 
that the contact angle of PVA/m PE/PA decreased compared 
to pure PVA. It was in agreement with our FTIR findings, 
which depicted the significant increase in OH intensity, con-
firming the hydrophilic nature of the nanocomposites. The 
contact angle of PVA was found to be 62° whereas the contact 
angle of PVA/mPE/PA was found to be 51°, which clearly 
indicates that the addition of mPE and PA into the PVA 
matrix improved wettability of the fabricated hybrid mem-
brane. Abdal-hay et al prepared electrospun nylon-6 scaffold 
blended with hydroxyapatite (HAp) for bone tissue formation. 
It was reported that the prepared nanocomposites showed 
hydrophilic nature and concluded that increased wettability is 
observed to be linked to enhanced bone regeneration.37
Tga
The TGA serves as a proof for chemical interactions and the 
formation of strong hydrogen bonds in the electrospun PVA 
and PVA/mPE/PA. The results of thermal analysis are shown 
in Figure 6. The results clearly showed that the pure PVA 
°
Figure 6 Tga of PVa membrane and PVa/mPe/Pa nanocomposites.
Abbreviations: mPe, metallocene polyethylene; Pa, plectranthus amboinicus; PVa, 
polyvinyl alcohol; Tga, thermogravimetric analysis.
Figure 5 Pore size distribution of (A) PVa membrane and (B) PVa/mPe/Pa nanocomposites.
Note: *Mean differences were significant compared with pure PVA (P,0.05).
Abbreviations: mPe, metallocene polyethylene; Pa, plectranthus amboinicus; PVa, polyvinyl alcohol.




Sample Average contact 
angle (°)
1 Pure PVa 62±1.19
2 PVa/mPe/Pa nanocomposites 51±1.32*
Note: *Mean differences were significant compared with pure PVA (P,0.05).
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displayed two-stage degradation and the PVA/mPE/PA nano-
fibers depicted stages of degradation indicating lower thermal 
stability compared to control. The PVA/mPE/PA nanofibers 
showed initial onset temperature of 56°C whereas the onset 
temperature value for pure PVA was found to be 274°C, 
which clearly indicates that the developed nanocomposites 
exhibited lower thermal stability. The reason for lower ther-
mal stability was due to the presence of water molecules in the 
PVA matrix due to the addition of PA. Balaji et al fabricated 
polyurethane (PU) scaffold blended with honey and papaya 
fibers. It was observed that the addition of the papaya and 
honey into the PU matrix decreased the degradation of tem-
perature, and our obtained results resemble the similar find-
ings.38 Abdullah et al prepared a PVA scaffold blended with 
aloe vera using electrospinning technique. It was reported that 
the addition of aloe vera into the PVA matrix decreased the 
degradation temperature due to the high water content pres-
ent in the aloe vera.35 Our developed hybrid nanocomposites 
showed decreased thermal stability, which might be due to the 
water molecules present in the fabricated nanocomposites.
Mechanical properties
The results of tensile strength and modulus for pure PVA 
and PVA/mPE/PA nanocomposites were shown in Figure 7. 
The electrospun PVA/mPE/PA nanocomposites exhibited 
higher tensile strength compared to the pure PVA nanofibers. 
The developed hybrid nanocomposites showed a tensile 
strength of 3.55±0.29 MPa, while for PVA, it was found 
to be 1.8±0.52 MPa. The mechanical testing results clearly 
revealed that the blending of the mPE into the PVA matrix has 
improved the tensile properties of the electrospun PVA nano-
fibers. Linh and Lee prepared a PVA scaffold blended with 
gelatin fibers for bone tissue engineering. It was reported that 
the tensile strength of pure PVA was 0.85±0.60 MPa while a 
PVA-blended gelatin membrane exhibited a tensile strength 
of ~4.20±0.40 and concluded the fabricated PVA/gelatin 
membrane as a suitable candidate for bone tissue formation.30 
In our developed nanocomposites, the tensile strength was 
found to be within the range of the above reported value and 
it might be used as a scaffold for the bone tissue formation.
Functionalization
The functionalization of PVA and PVA/mPE/PA nano-
composites was obtained using a heating method. The 
dissolution percentage of unfunctionalized PVA and 
PVA/mPE/PA nanocomposites after 1, 7, and 14 days is 
listed in Table 2. The SEM images of the functionalized PVA 
Table 2 Dissolution percentage of unfunctionalized and func-
tionalized PVa and PVa/mPe/Pa nanocomposites








1 100 0 0
7 100 0.39±0.07 0.46±0.02
14 100 1.26±0.30 1.65±0.57
Note: *Mean differences were significant compared with unfunctionalized PVA and 
PVa/mPe/Pa nanocomposites (P,0.05).


















































Figure 7 Mechanical testing of (A) PVa membrane and (B) PVa/mPe/Pa nanocomposites.
Note: *Mean differences were significant compared with pure PVA (P,0.05).
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Development and blood compatibility assessment of electrospun PVa/mPe/Pa
and PVA/mPE/PA nanocomposites after 1, 7, and 14 days 
are shown in Figures 8A and B, 9A and B, and 10A and B, 
respectively. The heat treatment improved the degradation 
behavior of the PVA membrane. It was reported that the 
heat treatment causes an increase in entanglements of longer 
polymer chains, which results in an increase in molecular 
weight. Furthermore, an increase in molecular weight reduces 
the formation of crystals, which favored the decreased weight 
loss.39 In our study, heat treatment might reduce the forma-
tion of crystals in PVA nanofibers, which ultimately reduces 
the weight loss in water. Asran et al prepared a nanofibrous 
scaffold based on PVA blended with collagen and HAp for 
bone tissue engineering. It was reported that the addition 
of HAp into the PVA matrix reduced the crystal structure 
of the PVA, which favored the reduction in weight losss.32 
Hence, in our study, the addition of mPE and PA might also 
be the reason for decreasing the size of the crystal structure of 
the PVA, which resulted in a reduced weight loss. Similarly, 
in a recent study, Hong prepared a PVA scaffold blended 
with AgNO
3
 nanoparticles and performed heat treatment 
under ultra violet (UV) lamp. It was reported that the heat 
treatment of electrospun PVA/AgNO
3
 made them insoluble 
in a moist environment.40 Hence, functionalizing the PVA 
using heat renders the nanocomposite insoluble in an aqueous 
environment. The functionalized PVA was explored for its 
blood compatibility in order to assess its safety.
Figure 8 seM images of functionalized (A) PVa membrane and (B) PVa/mPe/Pa nanocomposites after 1 day.
Abbreviations: mPe, metallocene polyethylene; Pa, plectranthus amboinicus; PVa, polyvinyl alcohol; seM, scanning electron microscopy.
Figure 9 seM images of functionalized (A) PVa membrane and (B) PVa/mPe/Pa nanocomposites after 7 days.
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The blood compatibility assessments play a significant role 
in deciding the application of developed implants in biomedi-
cal applications. When the implants contact with the blood, 
they absorb more plasma proteins and also enhance platelet 
surface interaction, which causes the thrombus formation, 
which ultimately results in the failure of the implants. 
Hence, it is required to design an implant, which should 
minimize the plasma protein adsorption and increase the 
thromboresistance.41 The formation of thrombus was initiated 
by a blood coagulation cascade, which follows two pathways, 
namely the intrinsic and extrinsic pathways. In the intrinsic 
pathway, the coagulation of blood was activated by plasma 
factors whereas, in the extrinsic pathway, the blood coagula-
tion was activated by tissue factors.42 The APTT assay deter-
mines the blood compatibility through the intrinsic pathway 
while the PT determines blood compatibility through the 
extrinsic pathway. The results of the APPT and PT assays are 
shown in Figure 11. It was observed that the PVA/mPE/PA 
matrix showed delayed blood clotting time compared with 
pure PVA. For the APTT assay, the blood clotting time of 
PVA/mPE/PA was found to be 177±3.05 s whereas, for pure 
PVA, the blood clotting was found to be 147±3.6 s. Similarly, 
for the PT assay, the blood clotting time of PVA/mPE/PA 
was found to be 75±2.0 s whereas, for pure PVA, the blood 
clotting time was observed to be 61±2.0 s. Hence, the addi-
tion of mPE and PA into the PVA matrix improved the 
anticoagulant and thrombogenic nature of pure PVA. Fur-
thermore, hemolysis was performed to investigate the safety 
of RBCs on the electrospun PVA/mPE/PA nanocomposites. 
The results of the hemolysis assay are shown in Figure 12. 
From results obtained, the hemolytic index of pure PVA was 
1.6% while, for electrospun PVA/mPE/PA nanocomposites, 
the index was only 0.6%. It was reported, if the hemolysis 
percentage was .2%, the material was considered as hemo-
lytic material, and when the percentage was ,2%, then the 
material was considered as nonhemolytic material.43 Hence 
our fabricated nanocomposites showed only 0.6%, which 
was ,1% indicating nonhemolytic material. A recent report 
suggested that the blood compatibility is influenced by a 
combination of factors such as surface roughness, surface 
energy and surface tension, surface wettability, and fiber 
Figure 10 seM images of functionalized (A) PVa membrane and (B) PVa/mPe/Pa nanocomposites after 14 days.
Abbreviations: mPe, metallocene polyethylene; Pa, plectranthus amboinicus; PVa, polyvinyl alcohol; seM, scanning electron microscopy.
Figure 11 aPTT and PT assays of PVa membrane and PVa/mPe/Pa nanocom-
posites.
Note: *Mean differences were significant compared with pure PVA (P,0.05).
Abbreviations: aPTT, activated partial thromboplastin time; mPe, metallocene 
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Development and blood compatibility assessment of electrospun PVa/mPe/Pa
diameters.44 Hence, the prediction of the combinational 
factors affecting the blood compatibility of the developed 
nanocomposites is cumbersome. Vincent et al developed 
multiple scaffolds based on degarapol and PLGA and inves-
tigated the significance of blood compatibility on different 
fiber diameters. It was reported that a small fiber diameter 
has a great influence in improving the blood compatibility 
of the fabricated nanocomposites.45 Manikandan et al pre-
pared a PU scaffold blended with murivenenai oil for tissue 
engineering applications. It was observed that the fabricated 
nanocomposites exhibited a hydrophilic nature indicating 
improved surface wettability. Furthermore, the PU-blended 
with murivennai oil nanocomposite showed improved blood 
compatibility compared with pure PU.46 In our study, the 
fabricated PVA/mPE/PA nanofibers exhibited smaller fiber 
diameter and improved surface wettability compared with the 
pure PVA fibers, which might be attributed to the enhanced 
blood compatibility.
Conclusion
In this study, we successfully fabricated a hybrid nanocom-
posite membrane based on PVA, mPE, and PA fibers. The 
hybrid nanocomposites exhibited reduced fiber diameter 
in the nanometer range and also a hydrophilic nature, as 
revealed in contact angle measurements. The mechanical 
results revealed that the hybrid membrane showed enough 
tensile strength required for bone tissue engineering. A hybrid 
nanocomposite comprising mPE, PVA and PA delayed blood 
clotting and displayed a low hemolytic index, indicating 
better blood compatibility. Hence, the newly developed 
nanocomposites mimicking the ECM structure might be a 
suitable scaffold for repairing bone defects.
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